2024
Prehospital Trauma Compendium: Fluid Resuscitation in Trauma – a Position Statement and Resource Document of NAEMSP
McMullan J, Curry B, Calhoun D, Forde F, Gray J, Lardaro T, Larrimore A, LeBlanc D, Li J, Morgan S, Neth M, Sams W, Lyng J. Prehospital Trauma Compendium: Fluid Resuscitation in Trauma – a Position Statement and Resource Document of NAEMSP. Prehospital Emergency Care 2024, ahead-of-print: 1-11. PMID: 39576138, DOI: 10.1080/10903127.2024.2433146.Peer-Reviewed Original ResearchEmergency medical servicesPrehospital trauma careTraumatic brain injuryTrauma carePrehospital trauma managementFluid usePrehospital providersIV fluidsVolume crystalloid resuscitationMedical servicesClinical careCrystalloid solutionTrauma resuscitationPosition statementCareWithholding fluidsBlood product administrationIndividual riskPolytrauma patientsTrauma managementMedical compatibilityIsotonic crystalloid solutionsResuscitationFluid resuscitationCrystalloid resuscitationRevisiting the use of adverse childhood experience screening in healthcare settings
Danese A, Asmussen K, MacLeod J, Meehan A, Sears J, Slopen N, Smith P, Sweeney A. Revisiting the use of adverse childhood experience screening in healthcare settings. Nature Reviews Psychology 2024, 3: 729-740. DOI: 10.1038/s44159-024-00362-5.Peer-Reviewed Original ResearchAdverse childhood experiences screenAdverse childhood experiencesImprove population mental healthMitigate adverse childhood experiencesPoor mental health outcomesPopulation mental healthMental health conditionsMental health decisionsMental health outcomesPublic health effortsDelivery of targeted interventionsModifiable risk factorsHealth outcomesMental illnessHealthcare settingsHealth effortsMental healthHealth decisionsHealth conditionsScreening measuresIntervention selectionImprove current practicesChildhood experiencesRisk factorsIndividual risk
2022
External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study
Raheem A, Landi I, Alowidah I, Capitanio U, Montorsi F, Larcher A, Derweesh I, Ghali F, Mottrie A, Mazzone E, De Naeyer G, Campi R, Sessa F, Carini M, Minervini A, Raman J, Rjepaj C, Kriegmair M, Autorino R, Veccia A, Mir M, Claps F, Choi Y, Ham W, Santok G, Tadifa J, Syling J, Furlan M, Simeone C, Bada M, Celia A, Carrión D, Bazan A, Ruiz C, Malki M, Barber N, Hussain M, Micali S, Puliatti S, Ghaith A, Hagras A, Ghoneem A, Eissa A, Alqahtani A, Rumaih A, Alwahabi A, Alenzi M, Pavan N, Traunero F, Antonelli A, Porcaro A, Illiano E, Costantini E, Rha K. External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study. International Journal Of Urology 2022, 30: 308-317. PMID: 36478459, DOI: 10.1111/iju.15108.Peer-Reviewed Original ResearchConceptsNew-onset CKDCKD stageChronic kidney disease developmentExternal validationCKD stage ICT1 renal massesKidney disease developmentPreoperative eGFRPatient ageConsecutive patientsMulticenter studyTumor sizePartial nephrectomyRenal massesProgression rateGood calibration propertiesStage IProgression probabilityPatientsNomogramIndividual riskCKDDisease developmentEGFRMedian valueEffect of out-of-village working activities on recent malaria exposure in the Peruvian Amazon using parametric g-formula
Carrasco-Escobar G, Rosado J, Nolasco O, White M, Mueller I, Castro M, Rodriguez-Ferruci H, Gamboa D, Llanos-Cuentas A, Vinetz J, Benmarhnia T. Effect of out-of-village working activities on recent malaria exposure in the Peruvian Amazon using parametric g-formula. Scientific Reports 2022, 12: 19144. PMID: 36351988, PMCID: PMC9645738, DOI: 10.1038/s41598-022-23528-8.Peer-Reviewed Original ResearchConceptsRecent malaria exposureMalaria exposurePopulation-based cross-sectional studyCommunity-level transmissionMalaria elimination strategiesCross-sectional studyPotential health benefitsWorking activitiesRisk differenceOccupational interventionsMalaria transmissionAdult populationOccupational activitiesHeterogeneous patternUnexposed populationIndividual riskHealth benefitsPopulation subgroupsRural areasElimination strategyVillage workersMean outcomeIntervention scenariosExposurePopulationLeft Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis.
Chew DS, Zhou K, Pokorney SD, Matchar DB, Vemulapalli S, Allen LA, Jackson KP, Samad Z, Patel MR, Freeman JV, Piccini JP. Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis. Annals Of Internal Medicine 2022, 175: 1230-1239. PMID: 35969865, DOI: 10.7326/m21-4653.Peer-Reviewed Original ResearchConceptsDirect oral anticoagulantsHigh bleeding riskLower stroke riskClinical effectiveness dataAtrial fibrillationBleeding riskStroke riskOral anticoagulantsIschemic strokeEffectiveness dataHAS-BLED scoreIndividual riskHigh stroke riskMajor bleeding riskNonvalvular atrial fibrillationPatient's individual riskPrimary end pointAtrial appendage occlusionBase-case analysisOral anticoagulationPrior strokeVASc scoreStroke preventionWatchman deviceAppendage occlusionTuberculosis attributed to transmission within healthcare facilities, Botswana—The Kopanyo Study
Smith JP, Modongo C, Moonan PK, Dima M, Matsiri O, Fane O, Click ES, Boyd R, Finlay A, Surie D, Tobias JL, Zetola NM, Oeltmann JE. Tuberculosis attributed to transmission within healthcare facilities, Botswana—The Kopanyo Study. Infection Control And Hospital Epidemiology 2022, 43: 1603-1609. PMID: 35382909, PMCID: PMC9535034, DOI: 10.1017/ice.2021.517.Peer-Reviewed Original ResearchConceptsElectronic medical recordsHealthcare facilitiesPopulation-based molecular epidemiologic studyMolecular epidemiologic studiesTB casesTB diagnosisTB transmissionTB epidemicMedical recordsTuberculosis diseaseBiologic plausibilityHealthcare workersIndividual patientsEpidemiologic studiesGeneral populationCommunity transmissionEtiologic agentTreatment dataClinical encountersPatientsEffective interventionsIndividual riskEMR dataTransmission eventsHigh-risk environments
2021
The trough of disillusionment: A critique of the “transition” paradigm
Gülöksüz S. The trough of disillusionment: A critique of the “transition” paradigm. European Psychiatry 2021, 64: s17-s17. PMCID: PMC9471660, DOI: 10.1192/j.eurpsy.2021.68.Peer-Reviewed Original Research
2020
Predicting risk of late age-related macular degeneration using deep learning
Peng Y, Keenan T, Chen Q, Agrón E, Allot A, Wong W, Chew E, Lu Z. Predicting risk of late age-related macular degeneration using deep learning. Npj Digital Medicine 2020, 3: 111. PMID: 32904246, PMCID: PMC7453007, DOI: 10.1038/s41746-020-00317-z.Peer-Reviewed Original ResearchLate age-related macular degenerationAge-related macular degenerationHigher prognostic accuracyClinical standardsMacular degenerationPrognostic accuracyIndependent cohortLargest longitudinal clinical trialsProbability of progressionSight-threatening stagesColor fundus photographsLongitudinal clinical trialsAMD patientsRetinal specialistsClinical trialsFundus photographsSpecialty clinicHigh riskClinical actionsSurvival analysisMedical interventionsIndividual riskAREDS2AREDSExternal validationPhysicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey.
Kurlander JE, Rubenstein JH, Richardson CR, Krein SL, De Vries R, Zikmund-Fisher BJ, Yang YX, Laine L, Weissman A, Saini SD. Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey. The American Journal Of Gastroenterology 2020, 115: 689-696. PMID: 32091419, PMCID: PMC7196016, DOI: 10.14309/ajg.0000000000000558.Peer-Reviewed Original ResearchConceptsProton pump inhibitorsPPI adverse effectsAdverse effectsHigh riskLong-term PPI useGastroesophageal reflux diseaseMultiple adverse effectsPPI useReflux diseasePPI discontinuationInhibitor riskMost internistsPump inhibitorsPhysicians' perceptionsInternists' perceptionsSignificant associationGeneral medicineDiscontinuationLogistic regressionClinical usePatientsFuture interventionsIndividual riskPreventionUGIB
2019
Hyperprogression after one dose of nivolumab in sinonasal cancer: A case report
Xiang JJ, Uy NF, Minja FJ, Verter EE, Burtness BA. Hyperprogression after one dose of nivolumab in sinonasal cancer: A case report. The Laryngoscope 2019, 130: 907-910. PMID: 31058321, DOI: 10.1002/lary.28042.Peer-Reviewed Original ResearchConceptsImmune checkpoint inhibitorsDose of nivolumabSquamous cell carcinomaSinonasal cancerCell carcinomaDisease progressionMaxillary sinus squamous cell carcinomaSinus squamous cell carcinomaNeck squamous cell carcinomaComplete vision lossICI initiationCheckpoint inhibitorsFirst doseLytic metastasesDistal metastasisCase reportIntracranial invasionVision lossImproved outcomesHyperprogressionIndividual riskDoseNivolumabCarcinomaMetastasis
2017
Condomless sex and HIV transmission among serodifferent couples: current evidence and recommendations
Koff A, Goldberg C, Ogbuagu O. Condomless sex and HIV transmission among serodifferent couples: current evidence and recommendations. Annals Of Medicine 2017, 49: 534-544. PMID: 28409656, DOI: 10.1080/07853890.2017.1320423.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsHIV transmissionSerodifferent couplesAntiretroviral therapyCondomless sexCondom useHIV-positive sexual partnerHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionPre-exposure prophylaxisHIV transmission riskUse of condomsInfected partnerHIV infectionHIV incidenceSexual transmissionHIV preventionPreventive benefitsVirus infectionCurrent evidencePrevention strategiesSexual partnersTransmission riskIndividual riskSexInfectionSurveillance Mammography in Older Patients With Breast Cancer—Can We Ever Stop?: A Review
Freedman RA, Keating NL, Partridge AH, Muss HB, Hurria A, Winer EP. Surveillance Mammography in Older Patients With Breast Cancer—Can We Ever Stop?: A Review. JAMA Oncology 2017, 3: 402-409. PMID: 27892991, PMCID: PMC5540165, DOI: 10.1001/jamaoncol.2016.3931.Peer-Reviewed Original ResearchConceptsBreast cancer survivorsSurveillance mammographyAnticipated life expectancyOlder patientsBreast eventsBreast cancerCancer survivorsOlder survivorsHormonal therapyLife expectancyContralateral breast cancer riskOlder breast cancer survivorsAnnual surveillance mammographyIndividual riskPatient's individual riskCancer-related causesResidual breast tissueWomen 70 yearsBreast cancer riskBreast cancer screeningContralateral cancerMammographic surveillanceLocal therapyHealthy womenCancer screening
2016
How to Use Type 2 Diabetes Treatments in Clinical Practice: Combination Therapies
Inzucchi S, Matthews D. How to Use Type 2 Diabetes Treatments in Clinical Practice: Combination Therapies. 2016, 471-492. DOI: 10.1002/9781118924853.ch33.Peer-Reviewed Original ResearchType 2 diabetesMultiple pathophysiological defectsGlucose-lowering agentsSide effect profileAmerican Diabetes AssociationRecent position statementStudy of DiabetesMechanism of actionComplementary regimensManagement of peopleDiabetes AssociationCombination therapyPathophysiological defectsAntihyperglycemic agentsDrug therapyClinical practiceType 2Clinical useEuropean AssociationDiabetesIndividual riskPosition statementTherapyAssociationRegimens
2015
Family history of skin cancer is associated with early-onset basal cell carcinoma independent of MC1R genotype
Berlin NL, Cartmel B, Leffell DJ, Bale AE, Mayne ST, Ferrucci LM. Family history of skin cancer is associated with early-onset basal cell carcinoma independent of MC1R genotype. Cancer Epidemiology 2015, 39: 1078-1083. PMID: 26381319, PMCID: PMC4679454, DOI: 10.1016/j.canep.2015.09.005.Peer-Reviewed Original ResearchConceptsEarly-onset basal cell carcinomaBasal cell carcinomaFamily historySkin cancerAge of onsetLifestyle factorsBenign skin conditionsStrong risk factorFirst-degree relativesMC1R genotypeCell carcinomaRisk factorsAge 40High riskLifestyle characteristicsAge 50Particular malignancySkin conditionsBCC casesCancerGenetic susceptibilitySaliva samplesMultivariate modelIndividual riskAffected relatives
2013
Contribution of health status and prevalent chronic disease to individual risk for workplace injury in the manufacturing environment
Kubo J, Goldstein BA, Cantley LF, Tessier-Sherman B, Galusha D, Slade MD, Chu IM, Cullen MR. Contribution of health status and prevalent chronic disease to individual risk for workplace injury in the manufacturing environment. Occupational And Environmental Medicine 2013, 71: 159. PMID: 24142977, PMCID: PMC3932962, DOI: 10.1136/oemed-2013-101653.Peer-Reviewed Original ResearchConceptsAcute occupational injuryHazard of injuryHeart diseaseChronic diseasesOccupational injuriesInjury riskIschemic heart diseasePrevalent chronic diseasesChronic heart diseaseOccupational injury riskMultiple injuriesPotential confoundersMedical claimsReportable injuryHealth statusInjuryOnly depressionDiseaseDiabetesStudy periodIndividual riskHealth metricsWorkplace injuriesDepressionHypertension
2012
Lessons learned from the first wave of aging with HIV
Justice AC, Braithwaite RS. Lessons learned from the first wave of aging with HIV. AIDS 2012, 26: s11-s18. PMID: 22781174, PMCID: PMC5596448, DOI: 10.1097/qad.0b013e3283558500.Peer-Reviewed Original Research
2011
Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants
Goldhaber-Fiebert JD, Jeon CY, Cohen T, Murray MB. Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants. International Journal Of Epidemiology 2011, 40: 417-428. PMID: 21252210, PMCID: PMC3621385, DOI: 10.1093/ije/dyq238.Peer-Reviewed Original ResearchConceptsDiabetes prevalenceTB prevalenceSocial determinantsHigh TB burdenBody mass indexHigh tuberculosis burdenType 2 diabetesIndividual-level risk factorsWorld Health SurveyTB burdenDiabetes mellitusPrevalent tuberculosisTuberculosis burdenMass indexIndividual-level riskBody of evidenceRisk factorsHealth SurveyDiabetesTuberculosisPrevalenceLow-income countriesHealth policyIndividual riskPopulation health
2006
Does “Clock” Matter in Prostate Cancer?
Zhu Y, Zheng T, Stevens RG, Zhang Y, Boyle P. Does “Clock” Matter in Prostate Cancer? Cancer Epidemiology Biomarkers & Prevention 2006, 15: 3-5. PMID: 16434577, PMCID: PMC2366206, DOI: 10.1158/1055-9965.epi-05-0631.Peer-Reviewed Original ResearchConceptsProstate cancerSex hormone levelsFemale breast cancerCommon cancer typesEvening shift workHormone levelsPrognostic biomarkerBreast cancerAndrogen expressionProstate tumorigenesisCancerCancer typesShift workDaily biochemicalIndividual riskEtiologyCircadian rhythmGenetic variantsRiskCircadian clockCircadian cycleBiomarkersPhysiologicProfound effect
2002
Identifying and Counseling Women at Increased Risk for Breast Cancer
Rhodes DJ. Identifying and Counseling Women at Increased Risk for Breast Cancer. Mayo Clinic Proceedings 2002, 77: 355-361. PMID: 11936931, DOI: 10.4065/77.4.355.Peer-Reviewed Original ResearchConceptsBreast cancerRisk factorsBreast cancer prevention clinical trialsCancer prevention clinical trialsPossible risk factorsPrevention clinical trialsRisk reductionRisk assessment toolLifestyle modificationProphylactic mastectomyClose surveillanceClinical trialsFamily historyCounseling womenNumerical risk estimatesCancerRisk estimatesIndividual riskSuch womenWomenRiskAbsence of consensusComplex family historiesAssessment toolOptions
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply